4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-19-035500
Options or other derivatives
- Chief Financial Officer acquired 26,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Plavan Matthew T Chief Financial Officer | 2019-06-03 | Grant or award · Stock Option (right to buy) | +26,000 | 109,450 | D | ||
Loading xslF345X03/doc4.xml…